Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
BMC Research Notes|June 3, 2015
The hypoxic tumor microenvironment and drug resistance against EGFR inhibitors: preclinical study in cetuximab-sensitive head and neck squamous cell carcinoma cell linesCarolien Boeckx, Jolien Van den Bossche, Ines De Pauw, et al.
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Characterization of acquired nutlin-3 resistant non-small cell lung cancer cellsChristophe Deben, Laurie Freire Boullosa, Andreas Domen, et al.
Plos One|October 25, 2012
Comparative analysis of dynamic cell viability, migration and invasion assessments by novel real-time technology and classic endpoint assaysRidha Limame, An Wouters, Bea Pauwels, et al.
Frontiers in Oncology|September 27, 2021
The Role of Akt in Acquired Cetuximab Resistant Head and Neck Squamous Cell Carcinoma: An <i>In Vitro</i> Study on a Novel Combination StrategyHannah Zaryouh, Ines De Pauw, Hasan Baysal, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|February 2, 2013
Expression analysis on archival material revisited: isolation and quantification of RNA extracted from FFPE samplesChristophe Deben, Karen Zwaenepoel, Carolien Boeckx, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 14, 2026
Hypoxia induces alterations in the volatile signature of pleural mesothelioma cellsEline Janssens, Ellen Heirwegh, An Wouters, et al.
Frontiers in Immunology|September 24, 2021
The Right Partner in Crime: Unlocking the Potential of the Anti-EGFR Antibody Cetuximab <i>via</i> Combination With Natural Killer Cell Chartering Immunotherapeutic StrategiesHasan Baysal, Ines De Pauw, Hannah Zaryouh, et al.
Molecular Imaging and Biology|January 6, 2016
Baseline [(18)F]FMISO μPET as a Predictive Biomarker for Response to HIF-1α Inhibition Combined with 5-FU Chemotherapy in a Human Colorectal Cancer Xenograft ModelSven De Bruycker, Christel Vangestel, Tim Van den Wyngaert, et al.
Cancers|January 18, 2019
Overcoming Intrinsic and Acquired Cetuximab Resistance in RAS Wild-Type Colorectal Cancer: An In Vitro Study on the Expression of HER Receptors and the Potential of AfatinibInes De Pauw, Filip Lardon, Jolien Van den Bossche, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|February 5, 2022
Microenvironment-driven intratumoral heterogeneity in head and neck cancers: clinical challenges and opportunities for precision medicineValentin Van den Bossche, Hannah Zaryouh, Marianela Vara-Messler, et al.
Pageof 7